Page 2 - Kodiak Sciences News Today

Research Analysts’ price target changes for Monday, April 1st: Apple (NASDAQ:AAPL) had its target price lowered by Loop Capital from $185.00 to $170.00. Loop Capital currently has a hold rating on the stock. Ameris Bancorp (NASDAQ:ABCB) had its target price lowered by Truist Financial Co. from $60.00 to $54.00. The firm currently has a buy […]

Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection...

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

Real-time index price for PHLX Swiss Franc (XDS), along with buy or sell indicators, analysis, charts, historical performance, news and more

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

Kodiak Sciences Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 260.49 million compared to USD 333.82 million a year...

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...

Kodiak Sciences (NASDAQ:KOD – Get Free Report) and Alector (NASDAQ:ALEC – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. Analyst Ratings This is a breakdown of recent […]

Alector (NASDAQ:ALEC – Get Free Report) and Kodiak Sciences (NASDAQ:KOD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Insider and Institutional Ownership 69.7% of Alector shares […]